Phase II proof concept study of RLM023 for Acne-vulgaris.
Phase of Trial: Phase II
Latest Information Update: 15 Mar 2018
At a glance
- Drugs Hypochlorous acid (Primary)
- Indications Acne vulgaris
- Focus Proof of concept; Therapeutic Use
- 15 Mar 2018 New trial record
- 12 Mar 2018 According to a Realm Therapeutics media release, company intends to file an Investigational New Drug (IND) application in early Q4 2018.